Pharmacological interventions for the treatment of Achilles tendinopathy: A systematic review of randomized controlled trials

British Medical Bulletin

Volumn 113, Issue 1, 2015, Pages 101-115

  Maffulli, Nicola ^a,b   Papalia, Rocco ^c   D'Adamio, Stefano ^c   Balzani, Lorenzo Diaz ^c   Denaro, Vincenzo ^c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF SALERNO   (Italy)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Achilles; conservative treatment; soft tissue therapy; tendinopathy; tendon pathology

Indexed keywords

APROTININ; BUPIVACAINE; CORTICOSTEROID; GLYCERYL TRINITRATE; LIDOCAINE; METHYLPREDNISOLONE ACETATE; POLIDOCANOL; MACROGOL DERIVATIVE; SCLEROSING AGENT;

ACHILLES TENDINITIS; ARTICLE; BLOOD AUTOTRANSFUSION; CELL THERAPY; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; PHYSIOTHERAPY; PRIORITY JOURNAL; PROLOTHERAPY; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGENERATIVE MEDICINE; REHABILITATION CARE; RISK ASSESSMENT; SCORING SYSTEM; SYSTEMATIC REVIEW; THROMBOCYTE RICH PLASMA; TREATMENT OUTCOME; ACHILLES TENDON; INJURIES; PAIN; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PROCEDURES; TENDINOPATHY; UNITED KINGDOM; WOUND HEALING;

ACHILLES TENDON; BLOOD TRANSFUSION, AUTOLOGOUS; HUMANS; PAIN; PLATELET-RICH PLASMA; POLYETHYLENE GLYCOLS; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCLEROSING SOLUTIONS; TENDINOPATHY; TREATMENT OUTCOME; UNITED KINGDOM; WOUND HEALING;

EID: 84924557337     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldu040     Document Type: Article

References (79)

1. Oliva F, Berardi AC, Misiti S, et al. Thyroid hormones and tendon: current views and future perspectives. Concise review. Muscles Ligaments Tendons J 2013; 3:201.
2. Maffulli N, Longo UG, Maffulli GD, et al. Achilles tendon ruptures in diabetic patients. Arch Orthop Trauma Surg 2011;131:33-8.
3. Van Dijk C, Van Sterkenburg M, Wiegerinck J, et al. Terminology for Achilles tendon related disorders. Knee Surg Sports Traumatol Arthrosc 2011;19:835-41.
4. Mandelbaum BR, Myerson MS, Forster R. Achilles tendon ruptures a new method of repair, early range of motion, and functional rehabilitation. Am J Sports Med 1995;23:392-5.
5. Weinreb JH, Sheth C, Apostolakos J, et al. Tendon structure, disease, and imaging. Muscle Ligaments Tendons J 2014;4:66-73.
6. Zhang Q, Joshi SK, Manzano G, et al. Muscle extracellular matrix degradation and contractibility following tendon rupture and disuse. Muscles Ligaments Tendons J 2013;3:35.
7. Tol JL, Spiezia F, Maffulli N. Neovascularization in Achilles tendinopathy: have we been chasing a red herring? Knee Surg Sports Traumatol Arthrosc 2012;20:1891-4.
8. Zafar MS, Mahmood A, Maffulli N. Basic science and clinical aspects of achilles tendinopathy. Sports Med Arthrosc 2009;17:190-7.
9. Perry M, Tillett E, Mitchell S, et al. The morphology and symptom history of the Achilles tendons of figure skaters: an observational study. Muscles Ligaments Tendons J 2012;2:108.
10. Vadalà A, Lanzetti R, Ciompi A, et al. Functional evaluation of professional athletes treated with a mini-open technique for achilles tendon rupture. Muscle Ligaments Tendons J 2014;4:177-81.
11. Gajhede-Knudsen M, Ekstrand J, Magnusson H, et al. Recurrence of Achilles tendon injuries in elite male football players is more common after early return to play: an 11-year follow-up of the UEFA Champions League injury study. Br J Sports Med 2013;47:763-8.
12. Shaikh Z, Perry M, Morrissey D, et al. Achilles tendino-pathy in club runners. Int J Sports Med 2012;33:390-4.
13. Maffulli N, Longo UG, Maffulli GD, et al. Achilles tendon ruptures in elite athletes. Foot Ankle Int 2011;32: 9-15.
14. Maffulli N, Sharma P, Luscombe KL. Achilles tendinopa-thy: aetiology and management. JRSM 2004;97:472-6.
15. Freedman B, Gordon J, Soslowsky L. The Achilles tendon: fundamental properties and mechanisms governing healing. Muscle Ligaments Tendons J 2014;4: 245-55.
16. Knobloch K. The role of tendon microcirculation in Achilles and patellar tendinopathy. J Orthop Surg Res 2008;3:1-13.
17. Maffulli N, Longo UG, Maffulli GD, et al. Marked pathological changes proximal and distal to the site of rupture in acute Achilles tendon ruptures. Knee Surg Sports Traumatol Arthrosc 2011;19:680-7.
18. Papalia R, Moro L, Franceschi F, et al. Endothelial dysfunction and tendinopathy: how far have we come? Musculoskelet Surg 2013;97:199-209.
19. Riley G. Tendinopathy-from basic science to treatment. Nat Clin Pract Rheumatol 2008;4:82-9.
20. van Sterkenburg MN, van Dijk CN. Mid-portion Achilles tendinopathy: why painful? An evidence-based philosophy. Knee Surg Sports Traumatol Arthrosc 2011;19:1367-75.
21. Kearney R, Costa ML. Insertional achilles tendinopathy management: a systematic review. Foot Ankle Int 2010;31: 689-94.
22. Wong J, Barrass V, Maffulli N. Quantitative review of operative and nonoperative management of Achilles tendon ruptures. Am J Sports Med 2002;30:565-75.
23. Wang C-J. Extracorporeal shockwave therapy in muscu-loskeletal disorders. J Orthop Surg Res 2012;7:1-8.
24. Frizziero A, Trainito S, Oliva F, et al. The role of eccentric exercise in sport injuries rehabilitation. Br Med Bull 2014;110:47-75.
25. Coombes BK, Bisset L, Vicenzino B. Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials. Lancet 2010;376:1751-67.
26. Paoloni JA, Appleyard RC, Nelson J, et al. Topical glyceryl trinitrate treatment of chronic noninsertional achilles tendinopathya randomized, double-blind, placebo-controlled trial. J Bone Joint Surg 2004;86:916-22.
27. Andres BM, Murrell GA. Treatment of tendinopathy: what works, what does not, and what is on the horizon. Clin Orthop Relat Res 2008;466:1539-54.
28. Coleman B, Khan K, Maffulli N, et al. Studies of surgical outcome after patellar tendinopathy: clinical significance of methodological deficiencies and guidelines for future studies. Scand J Med Sci Sports 2000;10:2-11.
29. DaCruz D, Geeson M, Allen M, et al. Achilles paraten-donitis: an evaluation of steroid injection. Br J Sports Med 1988;22:64-5.
30. Alfredson H, Öhberg L. Sclerosing injections to areas of neo-vascularisation reduce pain in chronic Achilles tendinopathy: a double-blind randomised controlled trial. Knee Surg Sports Traumatol Arthrosc 2005;13: 338-44.
31. Pearson J, Rowlands D, Highet R. Autologous blood injection for treatment of achilles tendinopathy? A randomised controlled trial. J Sport Rehabil 2012;21: 218-24.
32. Willberg L, Sunding K, Öhberg L, et al. Sclerosing injections to treat midportion Achilles tendinosis: a randomised controlled study evaluating two different concentrations of Polidocanol. Knee Surg Sports Traumatol Arthrosc 2008;16:859-64.
33. Bell KJ, Fulcher ML, Rowlands DS, et al. Impact of autologous blood injections in treatment of mid-portion Achilles tendinopathy: double blind randomised controlled trial. Br Med J 2013;0:346.
34. Brown R, Orchard J, Kinchington M, et al. Aprotinin in the management of Achilles tendinopathy: a randomised controlled trial. Br J Sports Med 2006;40:275-9.
35. de Jonge S, de Vos RJ, Weir A, et al. One-year follow-up of platelet-rich plasma treatment in chronic achilles tendinopathy a double-blind randomized placebo-controlled trial. Am J Sports Med 2011;39:1623-9.
36. de Vos RJ, Weir A, van Schie HT, et al. Platelet-rich plasma injection for chronic Achilles tendinopathy. JAMA 2010;303:144-9.
37. Kane TP, Ismail M, Calder JD. Topical glyceryl trinitrate and noninsertional achilles tendinopathy a clinical and cellular investigation. Am J Sports Med 2008;36:1160-3.
38. Kearney R, Parsons N, Costa M. Achilles tendinopathy management: a pilot randomised controlled trial comparing platelet-rich plasma injection with an eccentric loading programme. Bone Joint Res 2013;2:227-32.
39. Obaid H, Clarke A, Rosenfeld P, et al. Skin-derived fibro-blasts for the treatment of refractory Achilles tendinosis: preliminary short-term results. J Bone Joint Surg 2012;94:193-200.
40. Yelland MJ, Sweeting KR, Lyftogt JA, et al. Prolotherapy injections and eccentric loading exercises for painful Achilles tendinosis: a randomised trial. Br J Sports Med 2011;45:421-8.
41. Robinson J, Cook JL, Purdam C, et al. The VISA-A questionnaire: a valid and reliable index of the clinical severity of Achilles tendinopathy. Br J Sports Med 2001;35:335-41.
42. Rolf C, Movin T. Etiology, histopathology, and outcome of surgery in achillodynia. Foot Ankle Int 1997; 18:565-9.
43. Sharma P, Maffulli N. Tendon injury and tendinopathy: healing and repair. J Bone Joint Surg 2005;87:187-202.
44. Docking S, Samiric T, Scase E, et al. Relationship between compressive loading and ECM changes in tendons. Muscles Ligaments Tendons J 2013;3:7.
45. Castagna A, Cesari E, Garofalo R, et al. Matrix metallo-proteases and their inhibitors are altered in torn rotator cuff tendons, but also in the macroscopically and histolo-gically intact portion of those tendons. Muscles Ligaments Tendons J 2013;3:132.
46. Tresoldi I, Oliva F, Benvenuto M, et al. Tendon's ultra-structure. Muscles Ligaments Tendons J 2013;3:2.
47. Birch HL, Thorpe CT, Rumian AP. Specialisation of extracellular matrix for function in tendons and ligaments. Muscles Ligaments Tendons J 2013;3:12.
48. Alfredson H. Chronic midportion Achilles tendinopathy: an update on research and treatment. Clin Sports Med 2003;22:727-41.
49. Jozsa L, Kvist M, Balint B, et al. The role of recreational sport activity in Achilles tendon rupture A clinical, pathoanatomical, and sociological study of 292 cases. Am J Sports Med 1989;17:338-43.
50. Soldatis JJ, Goodfellow DB, Wilber JH. End-to-end operative repair of Achilles tendon rupture. Am J Sports Med 1997;25:90-5.
51. Thompson TC, Doherty JH. Spontaneous rupture of tendon of Achilles: a new clinical diagnostic test. J Trauma 1962;2:126-9.
52. Wang J. Can PRP effectively treat injured tendons? Muscle Ligaments Tendons J 2014;4:35-7.
53. Yamamoto E, Hata D, Kobayashi A, et al. Effect of beta-aminopropionitrile and hyaluronic acid on repair of collagenase-induced injury of the rabbit Achilles tendon. J Comp Pathol 2002;126:161-70.
54. Ma J, Shen J, Smith BP, et al. Bioprotection of tendon repair: adjunctive use of botulinum toxin A in Achilles tendon repair in the rat. J Bone Joint Surg 2007;89:2241-9.
55. Humphrey J, Chan O, Crisp T, et al. The short-term effects of high volume image guided injections in resistant non-insertional Achilles tendinopathy. J Sci Med Sport 2010;13:295-8.
56. Wright JG, Swiontkowski MF, Heckman JD. Introducing levels of evidence to the journal. J Bone Joint Surg 2003;85:1-3.
57. van Sterkenburg MN, de Jonge MC, Sierevelt IN, et al. Less promising results with sclerosing ethoxysclerol injections for midportion achilles tendinopathy a retrospective study. Am J Sports Med 2010;38:2226-32.
58. Andia I, Sánchez M, Maffulli N. Platelet rich plasma therapies for sports muscle injuries: any evidence behind clinical practice? Expert Opin Biol Ther 2011;11:509-18.
59. Kon E, Filardo G, Delcogliano M, et al. Platelet-rich plasma: new clinical application: a pilot study for treatment of jumper's knee. Injury 2009;40:598-603.
60. Yuan T, Zhang C-Q, Wang J. Augmenting tendon and ligament repair with platelet-rich plasma (PRP). Muscle Ligaments Tendons J 2013;3:139-49.
61. Maffulli N. Autologous blood products in musculoskel-etal medicine. Br Med J 2014;48:1392-3.
62. Maffulli N, Longo UG, Loppini M, et al. Current treatment options for tendinopathy. Expert Opin Pharmacother 2010;11:2177-86.
63. Zhang J, Wang J. PRP treatment effects on degenerative tendinopathy-an in vitro model study. Muscle Ligaments Tendons J 2014;4:10-7.
64. De Vos R, Weir A, Tol J, et al. No effects of PRP on ultra-sonographic tendon structure and neovascularisation in chronic midportion Achilles tendinopathy. Br J Sports Med 2011;45:387-92.
65. Dayer J. Chronic inflammatory joint diseases: natural inhibitors of interleukin 1 and tumor necrosis factor alpha. J Rheumatol 1991;27(Suppl):71.
66. Ehrlich MG, Armstrong AL, Treadwell BV, et al. Degradative enzyme systems in cartilage. Clin Orthop Relat Res 1986;213:62-8.
67. John Orchard M, FACSP F, Cardon-Dunbar A, et al. Successful management of tendinopathy with injections of the MMP-inhibitor aprotinin. Clin Orthop Relat Res 2008;466:1625-32.
68. Rukin NJ, Maffulli N. Systemic allergic reactions to aprotinin injection around the Achilles tendon. J Sci Med Sport 2007;10:320-2.
69. Ford LT, DeBender J. Tendon rupture after local steroid injection. South Med J 1979;72:827-30.
70. Juncosa-Melvin N, Boivin GP, Gooch C, et al. The effect of autologous mesenchymal stem cells on the biomechan-ics and histology of gel-collagen sponge constructs used for rabbit patellar tendon repair. Tissue Eng 2006;12:369-79.
71. Kryger GS, Chong AK, Costa M, et al. A comparison of tenocytes and mesenchymal stem cells for use in flexor tendon tissue engineering. J Hand Surg 2007;32:597-605.
72. Tolo VT. An expression of concern. J Bone Joint Surg 2013;95:2057-2057.
73. Hannallah D, Peterson B, Lieberman JR, et al. Gene therapy in orthopaedic surgery. Instr Course Lect 2003;52:753-68.
74. Nakamura N, Timmermann SA, Hart DA, et al. A comparison of in vivo gene delivery methods for antisense therapy in ligament healing. Gene Ther 1998;5:1455-61.
75. Chong AK, Ang AD, Goh JC, et al. Bone marrow-derived mesenchymal stem cells influence early tendon-healing in a rabbit achilles tendon model. J Bone Joint Surg Am 2007;89:74-81.
76. Young RG, Butler DL, Weber W, et al. Use of mesenchy-mal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res 1998;16:406-13.
77. Deng D, Liu W, Xu F, et al. Engineering human neo-tendon tissue in vitro with human dermal fibroblasts under static mechanical strain. Biomaterials 2009;30: 6724-30.
78. Deng D, Liu W, Xu F, et al. In vitro tendon engineering using human dermal fibroblasts. Zhonghua Yi Xue Za Zhi 2008;88:914-8.
79. Liu W, Chen B, Deng D, et al. Repair of tendon defect with dermal fibroblast engineered tendon in a porcine model. Tissue Eng 2006;12:775-88.